Susquehanna International Group, LLP Nevro Corp Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $471 - $1,010	100 Added 0.74%	13,600 $75,000
Q2 2024 Aug 15, 2024	SELL	$7.96 - $13.59 $102,684 - $175,311	-12,900 Reduced 48.86%	13,500 $113,000
Q1 2024 May 07, 2024	SELL	$13.56 - $20.78 $817,668 - $1.25 Million	-60,300 Reduced 69.55%	26,400 $381,000
Q4 2023 Feb 14, 2024	BUY	$14.18 - $22.31 $779,900 - $1.23 Million	55,000 Added 173.5%	86,700 $1.87 Million
Q3 2023 Nov 14, 2023	BUY	$18.22 - $25.85 $171,268 - $242,990	9,400 Added 42.15%	31,700 $609,000
Q2 2023 Aug 11, 2023	SELL	$22.62 - $39.32 $321,204 - $558,344	-14,200 Reduced 38.9%	22,300 $566,000
Q1 2023 May 16, 2023	SELL	$30.17 - $41.11 $90,510 - $123,330	-3,000 Reduced 7.59%	36,500 $1.32 Million
Q4 2022 Feb 14, 2023	SELL	$36.43 - $49.4 $1.48 Million - $2.01 Million	-40,700 Reduced 50.75%	39,500 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $784,737 - $1.02 Million	19,300 Added 31.69%	80,200 $3.74 Million
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $539,220 - $1.03 Million	-13,200 Reduced 17.81%	60,900 $2.67 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $2.1 Million - $3.23 Million	35,100 Added 90.0%	74,100 $5.36 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $907,983 - $1.36 Million	11,200 Added 40.29%	39,000 $3.16 Million
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $683,333 - $1.11 Million	6,700 Added 31.75%	27,800 $3.24 Million
Q2 2021 Aug 11, 2021	BUY	$141.6 - $179.06 $495,600 - $626,710	3,500 Added 19.89%	21,100 $3.5 Million
Q1 2021 May 17, 2021	SELL	$132.81 - $182.18 $2.11 Million - $2.9 Million	-15,900 Reduced 47.46%	17,600 $2.46 Million
Q4 2020 Feb 16, 2021	SELL	$138.17 - $184.34 $5.5 Million - $7.34 Million	-39,800 Reduced 54.3%	33,500 $5.8 Million
Q3 2020 Nov 16, 2020	SELL	$114.09 - $145.51 $2.89 Million - $3.68 Million	-25,300 Reduced 25.66%	73,300 $10.2 Million
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $6.59 Million - $9.57 Million	-73,700 Reduced 42.77%	98,600 $11.8 Million
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $5.02 Million - $10.3 Million	71,500 Added 70.93%	172,300 $17.2 Million
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $4.76 Million - $7.32 Million	62,300 Added 161.82%	100,800 $11.8 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $30,760 - $45,550	500 Added 1.32%	38,500 $3.31 Million
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $6.52 Million - $7.53 Million	-112,400 Reduced 74.73%	38,000 $2.46 Million
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $6.6 Million - $11.6 Million	-185,900 Reduced 55.28%	150,400 $9.4 Million
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $9.99 Million - $15.9 Million	281,900 Added 518.2%	336,300 $13.1 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $552,750 - $943,375	12,500 Added 29.83%	54,400 $3.1 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $5.96 Million - $7.62 Million	-82,400 Reduced 66.29%	41,900 $3.35 Million
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $2.81 Million - $3.58 Million	40,400 Added 48.15%	124,300 $10.8 Million
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $6.93 Million - $9.81 Million	-105,100 Reduced 55.61%	83,900 $5.79 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $15.3 Million - $17.2 Million	189,000	189,000 $17.2 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$16.6 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$14.1 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$13.6 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$9.21 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$7.9 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account